Spero Therapeutics
SPRO
SPRO
88 hedge funds and large institutions have $244M invested in Spero Therapeutics in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 94 → 88 (-6)
11% less capital invested
Capital invested by funds: $273M → $244M (-$29M)
30% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 20
Holders
88
Holding in Top 10
2
Calls
$1.31M
Puts
$711K
Top Buyers
| 1 | +$2.37M | |
| 2 | +$700K | |
| 3 | +$660K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$446K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$306K |
Top Sellers
| 1 | -$7.62M | |
| 2 | -$2.67M | |
| 3 | -$1.67M | |
| 4 |
Morgan Stanley
New York
|
-$1.66M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$730K |